Northwest & Ethical Investments’s Cipher Pharmaceuticals Inc. CPHR Stock Holding History

Northwest & Ethical Investments’s Portfolio CPHR Stock Details CPHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-472,670	Closed	-$1.72M	–	410
2016 Q4	$1.72M	Hold	472,670	–	–	0.12%	206
2016 Q3	$1.81M	Hold	472,670	–	–	0.13%	181
2016 Q2	$2.47M	Hold	472,670	–	–	0.19%	126
2016 Q1	$2.27M	Hold	472,670	–	–	0.15%	133
2015 Q4	$2.22M	Buy	472,670 +337,723	+250%	+$1.46M	0.16%	141
2015 Q3	$499K	Hold	134,947	–	–	0.04%	179
2015 Q2	$1.15M	Buy	134,947 +31,197	+30%	+$311K	0.08%	174
2015 Q1	$938K	Sell	103,750 -1,340	-1%	-$16.8K	0.07%	183
2014 Q4	$1.52M	Buy	+105,090	New	+$1.53M	0.1%	165

Other funds holding CPHR

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Northwest & Ethical Investments's CPHR Position: Q1 2017 in Review

Northwest & Ethical Investments sold out of Cipher Pharmaceuticals Inc. (CPHR) in Q1 2017, closing a stake of 472,670 shares — an estimated $1.72M sold.

Northwest & Ethical Investments first reported a position in CPHR in Q4 2014 and held it in 9 quarters. The position peaked at $2.47M in Q2 2016. 1 fund tracked by Wall St. Rank holds CPHR as of Q1 2017.

Northwest & Ethical Investments reported no remaining Cipher Pharmaceuticals Inc. position as of Q1 2017 after selling out during the quarter.
Northwest & Ethical Investments sold 472,670 Cipher Pharmaceuticals Inc. shares in Q1 2017, an estimated $1.72M.
Northwest & Ethical Investments first reported a position in Cipher Pharmaceuticals Inc. in Q4 2014 and held it in 9 quarters.
Northwest & Ethical Investments's Cipher Pharmaceuticals Inc. position peaked at $2.47M in Q2 2016.
1 fund tracked by Wall St. Rank held Cipher Pharmaceuticals Inc. as of Q1 2017.

Based on Northwest & Ethical Investments's 13F filing for Q1 2017, filed 8 Jul 2025.